BioSpace News Archive

Globe Life Inc. (NYSE: GL) will release First Quarter 2020 earnings after the market closes on Wednesday, April 22, 2020. At that time a copy of the Company’s Q1 - 2020 earnings press release and any other financial and statistical information about the quarter will be available on the Company’s website at https://investors.globelifeinsurance.com/ under Calls and Meetings.

- Cirrus Dx, Inc. (CirrusDx), an infectious disease laboratory and diagnostics company, received Emergency Use Authorization (EUA) from the US Food & Drug Administration (FDA) to perform SARS-COVID-19 testing. CirrusDx validated and will commercialize the Allplex™ 2019-nCoV Assay, a real-time Reverse Transcriptase PCR test de

Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its first quarter 2020 financial results will be released on Thursday, April 30, after the market closes.

A study led by UnitedHealth Group (NYSE: UNH) Research & Development and The Everett Clinic, part of Optum, revealed alternative swab materials and commonly available saline are effective for COVID-19 testing, providing more options for sample collection.

ImmunoGen, Inc. , (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the Company will host a conference call at 8:00 a.m. ET on Friday, May 1, 2020 to discuss its first quarter operating results. Management will also provide a brief update on the business. Conference Call Information To access the live call by phone, dial (877)

Accelerates the detection and identification of viral sequences and seamless submission to critical databases

Cutera, Inc. (NASDAQ: CUTR) (“Cutera”), a provider of laser and other energy-based aesthetic systems for practitioners worldwide, today announced that it has commenced an underwritten public offering of its common stock. In connection with the offering, Cutera intends to grant the underwriter a 30-day option to purchase up to an additional 15% of the shares of common stock sold in the offering. All of the shares in the

Profound Medical Corp. will announce its first quarter 2020 financial results after market close on Thursday, May 7, 2020.

True Diagnostics, Inc. announced today their Strategic Alliance to develop and commercialize VeraTePrep

Endo International plc (NASDAQ: ENDP) will announce its first–quarter 2020 financial results on May 7, 2020 and members of its senior management team will host a conference call and webcast at 8:00am ET before the U.S. financial markets open. The dial-in number to access the call is U.S./ Canada (866) 497-0462, International (67